According to altRx's own disclosure, compounded GLP-1 medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality
A Program Built on Medical Safety, Evidence-Based Evaluation, and Ongoing Monitoring Why Safety Matters in Medical Weight Loss Safety is the foundation of the Medical Weight Loss and GLP-1 Treatment Program
[DOI] [PMC free article] [PubMed] [Google Scholar] 104.Zhang Y., Wang X.L., Zhou M., Kang C., Lang H.D., Chen M.T., Hui S.C., Wang B., Mi M.T
nonetheless, the Researching cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial indicated no significant hepatobiliary adverse events in the dulaglutide cohort vs